Inflammatory Initiation & Amplification: ELISA Panels for Key Biomarkers

Inflammation is one of the most common early indicators in infection, sterile inflammation, tumor microenvironment, tissue injury, and drug safety evaluation. However, due to differences in time windows, sample types, and pathways, it is also highly susceptible to "misjudgment based on a single marker."

To help you more rapidly assess the inflammatory process and enhance the interpretability of conclusions, we have deconstructed "inflammatory initiation and amplification" into four experimental decision-making questions: whether inflammation is initiated, whether it is amplified through chemokine recruitment, whether the endothelial adhesion cascade is activated, and whether it is predominantly systemic/acute-phase response.

For each question, we provide corresponding standard panel (2 markers) and expanded panel (3–5 markers) detection combinations, covering multiple species (Human/Mouse/Rat, as well as Pig/Bovine/Dog/Rabbit, etc.). This enables you to quickly select products, reduce trial-and-error costs, and achieve more stable and reproducible comparisons between groups.

Typical Research Scene

Early Assessment of Infection/Aseptic Inflammation

Has inflammation been initiated? How is the intensity stratified?

Immunostimulatory model (e. g., LPS)

Pro-inflammatory initiation vs. recruitment amplification, has it occurred?

Pharmacodynamics/Safety

Is there a systemic acute phase (CRP/SAA)?

Vasculitis

Is the endothelial adhesion cascade activated?

Are you currently researching the following issues?

Is inflammation initiated?

Is it amplified via chemotactic recruitment?

Is the endothelium activated?

Is the response predominantly systemic/acute-phase?

CUSABIO Recommended Assay Panels

Research Question	Standard Panel (2 markers)	Expanded Panel (3–5 markers)	Quick Interpretation
Is inflammation initiated?	TNF-α + IL-6	TNF-α + IL-6 + IL-1β (± IL-10)	Initiation and intensity stratification: IL-1β indicates a stronger inflammatory context.
Is it amplified via chemotactic recruitment?	CCL2(MCP-1) + CXCL1	CCL2 + CXCL1 + CXCL8(IL-8) (± GM-CSF)	Elevated recruitment signals = amplification trend; more stable when combined with initiation markers.
Is the endothelium activated?	ICAM-1 + VCAM-1	ICAM-1 + VCAM-1 + E-selectin (± P-selectin)	Adhesion cascade readouts: suitable for vascular inflammation/infiltration-related models.
Is the response predominantly systemic/acute-phase?	CRP + IL-6	CRP + SAA + IL-6 (± TNF-α)	Acute-phase proteins reflect systemic response; IL-6 often serves as a driving clue.

Sample Type and Time Point Suggestion:

Sample Type: Cell supernatant is suitable for capturing initiation and chemotactic signals.;Serum/plasma is more suitable for systemic acute phase; tissue homogenates require attention to matrix interference and normalization.
Time point: Indicators often appear early; chemotactic and endothelial signals may lag; acute-phase proteins are more indicative of systemic stages. It is recommended to compare at least two time windows: "early" and "mid."
Comparability: When making conditional comparisons, try to keep the same set of conditions fixed.Detection indicators,Only change the stimulus/dosage/treatment to avoid incomparable conclusions due to switching indicators.

Experimental Objectives + Recommended Combinations Detailed

Question 3: Is the endothelium activated (Endothelial Activation & Adhesion Cascade)?

In many inflammatory models, cells do not simply "come and go as they please" when entering tissues; they must first traverse the vascular endothelium. Rolling—Adhering—Traversing Process. Endothelial activation (upregulation of adhesion molecules) is a critical gatekeeper for transitioning from "signaling" to "actual infiltration" in recruitment, and is often associated with changes in vascular permeability and exacerbation of organ damage. If your research involves vascular inflammation, organ perfusion/damage, immune cell transendothelial migration, or if you aim to connect "chemotactic signaling" with "actual tissue entry" into a closed loop, this layer of readout is essential.

Standard Panel (2 markers):ICAM-1 + VCAM-1

Expanded Panel (3-5 markers):ICAM-1 + VCAM-1 + E-selectin (±P-selectin)

Key Points of Interpretation:

Upregulation of endothelial adhesion molecules is a core step in leukocyte adhesion and transendothelial migration. It is suitable for models of vascular inflammation, tissue infiltration, and inflammation-related vascular responses. When combined with chemokines, it can form a closed-loop explanation of "recruitment signals + adhesion pathways."

Recommended Products:

Choose your experimental species:

Mouse Human Rat Dog

Select the markers to detect:

ICAM1 ICAM1 SELP VCAM1

Product Citation (Part):

Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin a2b1. Cell Metabolism, 2024. (IF=30.9)

CUSABIO ELISA kits used in this study:

Rat Arachidonic Acid(AA) ELISA Kit;CSB-E13008r

Rat D-Dimer,D2D ELISA Kit;CSB-E12984r

Rat Thromboxane B2,TXB2 ELISA Kit;CSB-E08047r

Mouse P-Selectin ELISA kit;CSB-E04709m

Mouse D-Dimer,D2D ELISA Kit;CSB-E13584m

Mouse Interleukin 6,IL-6 ELISA KIT;CSB-E04639m

Mouse ferritin,FE ELISA Kit;CSB-E08827m

Platelet membrane coating coupled with solar irradiation endows a photodynamic nanosystem with both improved antitumor efficacy and undetectable skin damage. Biomaterials, 2018. (IF=12.8)

CUSABIO ELISA kits used in this study:

Mouse P-Selectin ELISA kit;CSB-E04709m

References:

Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76(2):301–314.
Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689.

Why Choose CUSABIO ELISA Kit?

More comprehensive coverage, convenient for panel creation

Common species (Human/Mouse/Rat) are comprehensively covered, and support forPig/Bovine/Dog/Rabbit, etc.Multi-species, suitable for cross-model and cross-species comparative studies.

Quality control is more clearly defined

Validation was conducted around key indicators such as detection range, sensitivity, specificity, linearity, recovery rate, and intra-/inter-batch precision, resulting in more stable and reproducible outcomes. (Click to view the 8 major quality control standards of CUSABIO ELISA kits.)

Sample compatibility is broader

Supports common sample types such as serum/plasma, cell supernatant, tissue homogenate/lysate, and adapts to different reading requirements from "initiation" to "systemic acute phase."

Ready-to-use for greater convenience

Complete facilities and standardized processes reduce preparation work and human error.

Global Customer Recognition

Currently, CUSABIO products have reached customers worldwide, with product citations in literature.Over 30, 000 articles, some published in Nature,Cell、Cell research、 High-impact journals such as Immunity. (Click to view CUSABIO 30000+ product citation literature)

FAQ

Q: Should I prioritize assessing "initiation" or "amplification/endothelial activation/acute phase"? +

A: Typically, start with stratification for “initiation” (TNF-α/IL-6). If initiation is positive but the phenotype is not evident, then assess "amplification" (CCL2/CXCL1/IL-8). Add "endothelial activation" when vascular involvement or strong infiltration is relevant. Consider "acute phase" (CRP/SAA) if systemic inflammation, efficacy, or safety concerns are suspected.

Q: Why is CCL2 (MCP-1) recommended for the amplification layer? +

A: CCL2 (MCP-1) is a frequently used chemokine readout for monocyte/macrophage recruitment and is commonly employed to assess whether inflammation has progressed from "initiation" to "recruitment and amplification." When used together with initiation markers, it enables a more robust assessment of the stage.

Q: When is it necessary to add the endothelial activation layer? +

A: When your readouts are strongly associated with vascular permeability, leukocyte adhesion and migration, tissue infiltration, vascular inflammation, or organ damage, ICAM-1/VCAM-1/selectins often provide a more direct mechanistic explanation and bring you closer to understanding "what is actually happening" compared to pro-inflammatory cytokines alone.

Q: What is the relationship between acute phase proteins CRP/SAA and IL-6? +

A: Acute phase proteins reflect systemic responses; IL-6 is often regarded as a key driver of the acute phase response. Combined observation helps distinguish between "local inflammation" and "systemic inflammation" tendencies, but interpretation should still be integrated with the model and sampling site.

Note: This page only provides indicator selection and result interpretation guidance; specific experimental conditions should be validated according to your model and substrate.

Inflammatory Initiation & Amplification